Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 436 AL 450

Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes

Minauro-Sanmiguel F, Vargas-Perez H.

Neuroscience. 2026 Apr 6;599:162-169. doi: 10.1016/j.neuroscience.2026.02.028. Epub 2026 Feb 16.

Brain peptides in Alzheimer's disease - pathophysiology and therapeutic advances

Pahal S, Gupta A, Kumar V, Singh P, Kaushik M, Pahal V, Atluri G, Chaudhary A.

Cell Tissue Res. 2026 Mar 3;403(3):28. doi: 10.1007/s00441-026-04055-8.

Wake-promoting neuromodulators in Alzheimer's disease: Implications for sleep and brain clearance

Pedersen TJ, Clemens SG, Winer JR, Sharma A, Falgàs N, Lucey BP, Gordon BA, Musiek ES.

Alzheimers Dement. 2026 Mar;22(3):e71298. doi: 10.1002/alz.71298.

Drug repurposing in Alzheimer's disease: Emerging therapeutic strategies and promising candidates

More PS, Rangari SW, Lade SN, Unidrwade DS, Burle SS, Umekar MJ, Lohiya RT, Zanwar AS.

Ageing Res Rev. 2026 Jun;118:103113. doi: 10.1016/j.arr.2026.103113. Epub 2026 Apr 7.

Traditional Chinese Medicine and Ferroptosis in Alzheimer's Disease: A Potential Therapeutic Approach

Liu A, Xing L, Li J, Yao M, Song J, Guo W, Duan P, Li H.

Drug Des Devel Ther. 2026 Mar 9;20:590868. doi: 10.2147/DDDT.S590868. eCollection 2026.

[New therapies and ongoing clinical trials in Alzheimer's disease]

Andersen P, Bonnard A, Börjesson Hanson A, Kivipelto M.

Lakartidningen. 2026 May 20;123:25147.

The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial

Mummery CJ, Mayorga AJ, Simmons A, Chow TW, Burgess B, Nguyen T, Gao J, Budda B, Park LQ, Gupta R, Li C, Shi L, Kenkare-Mitra S, Rosenthal A, Paul R, Ward M, Purcell DD, Salloway S, Grundman M, Romano G, Salvadore G.

Nat Med. 2026 May;32(5):1708-1716. doi: 10.1038/s41591-026-04273-1. Epub 2026 Mar 5.

[Sleep disorders in Alzheimer's disease]

Kolmakova KA, Lobzin VY, Emelin AY.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):56-62. doi: 10.17116/jnevro202612604256.

Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Alzheimer's Disease: A Real‑World Retrospective Cohort Study with Treatment Effect Heterogeneity Analysis

Jiang C, Krivinko J, Yu Z, Sweet RA, Zeng L, Wang H, Ding Y, Zeng Z, Kofler J, Wang L.

CNS Drugs. 2026 Jun;40(6):823-833. doi: 10.1007/s40263-026-01286-9. Epub 2026 Mar 28.

Comparative risk of the neurodegenerative outcomes between sodium-glucose co-transporter 2 (SGLT2) inhibitors and thiazolidinediones in type 2 diabetes: a multicentre cohort study using the Korean healthcare database (2014-2025)

Park SJ, Kim HJ, Seo M, Byun DW, Suh K, Yoo MH, Yang H, Lee I, Kwon SH, Kim M, Mok JO, Kim DY, Sohn SY, Park RW, Seo WW, Kwon SY, Rhee SY, Kwon JM, Cha JM, Park HK.

BMJ Open. 2026 Feb 22;16(2):e105271. doi: 10.1136/bmjopen-2025-105271.

Alzheimer's disease in patients prescribed statins: A real-world data analysis of U.S. patient health records

Novak DA, Saleem N, Gerhardt PC, Maestas D, Kejriwal N, Vaezazizi E, Murray I, Al-Khoury L.

J Alzheimers Dis. 2026 Apr;110(3):1474-1489. doi: 10.1177/13872877261424220. Epub 2026 Feb 27.

Potential Therapeutic Effects and Mechanisms of Estrogen on Diabetes, Alzheimer's Disease,and Their Comorbidity:A Review

Liu CW, Shan ZX, Li WJ, Qu QW, Hou XQ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2026 Apr;48(2):328-337. doi: 10.3881/j.issn.1000-503X.16649.

Racial and Ethnic Reporting and Representation in US Alzheimer Clinical Trials: A Systematic Review

Lin Z, Sun R, Ross JS, Lau K, Stumpf S, Chen X.

JAMA Netw Open. 2026 Mar 2;9(3):e262427. doi: 10.1001/jamanetworkopen.2026.2427.

Investigating gender differences in Alzheimer's disease

Ibrahim Fouad G, Ando H, Ichihara G.

J Alzheimers Dis. 2026 Feb;109(4):1525-1541. doi: 10.1177/13872877251410204. Epub 2026 Jan 5.

The efficacy and safety of Yokukansan for concomitant behavioral and psychological symptoms of Alzheimer's disease: a randomized, double-blinded clinical trial

Yuan M, Gu C, Nguyen TTT, Xu L, Chen X, Sun J, Zhong L, Zheng Y, Zhang L, Lu Q, Yuan C, Xu H.

J Ethnopharmacol. 2026 Jul 15;366:121644. doi: 10.1016/j.jep.2026.121644. Epub 2026 Apr 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias